MERLIN
Live / Registered — Registered (as of 09 Nov 2021)
What this means for you
Registered since 09 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79303109
- Registration number
- 6549735
- Mark type
- Stylized text
- Filed
- 26 Oct 2020
- Published for opposition
- 24 Aug 2021
- Registered
- 09 Nov 2021
- Attorney of record
- James C. Watson
Goods and services
- Class 005 — Pharmaceuticals: Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely medical diagnostic reagents and assays for testing of tissue for use in disease detection, namely oncology; preparations for detecting mutation in human genes for medical purposes
- Class 042 — Scientific and technological services: Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers; development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the fields of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer
- Class 044 — Medical, beauty and agricultural services: Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
Owner
- SkylineDx B.V., NL
- SkylineDx B.V., NL
- SkylineDx B.V., NL
Prosecution history
- 24 May 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 May 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 May 2022 — FINAL DISPOSITION PROCESSED
- 09 Feb 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 24 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Aug 2021 — PUBLISHED FOR OPPOSITION
- 22 Aug 2021 — NOTIFICATION PROCESSED BY IB
- 04 Aug 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Aug 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 04 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jul 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jul 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jul 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED